Conditional Approval to List on the Toronto Stock Exchange LIMERICK, Ireland, Oct. 25, 2021 /CNW/ - kneat.com, inc. (TSXV: KSI) ("Kneat" or the "Company") a leader in digitizing and automating validation processes, is pleased to announce that it has received conditional approval to uplist (the "Uplisting") its common shares (the "Common Shares") to the Toronto Stock Exchange (the "TSX") from the TSX Venture Exchange (the "TSXV").
"Listing on Canada's largest exchange is a significant milestone for the Company and will help to increase brand recognition. This will broaden the Company's visibility and access to domestic and international institutional investors seeking to invest in one of the world's leading validation software companies," said Eddie Ryan, CEO of Kneat.
Final approval of the Uplisting is subject to the Company meeting certain conditions required by the TSX. Upon completion of the final listing requirements, the Company's Common Shares will be delisted from the TSXV. Kneat common shares will continue to trade under the stock symbol "KSI" upon listing on the TSX. The Company will issue a press release once the expected commencement date for trading of Kneat's Common Shares on the TSX is confirmed.
About Kneat
Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the next generation Kneat Gx SaaS platform. Multiple business work processes can be configured on the platform from equipment to computer system validation, through to quality document management. Kneat's software allows users to author, review, approve, execute testing online, manage any exceptions, and post approve final deliverables in a controlled FDA 21 CFR Part 11/ Eudralex Annex 11 compliant platform. Macro and micro report dashboards enable powerful oversight into all systems, projects and processes globally. Customer case studies are reporting productivity improvements in excess of 100% and a higher data integrity and compliance standard. For more information visit www.kneat.com.